Tirzepatide, a novel medication, is creating significant interest in the healthcare community as a possible treatment for both type 2 diabetes and reducing body fat. This dual-action drug works by targeting two different receptors, GLP-1 and GIP, leading to enhanced glucose control and significant fat loss in research studies . While initial data a